Plain-English translation of NCT04077099 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new medication called for people with advanced lung cancer that has a specific genetic change. The study has two parts: first, doctors will find the safest dose of the medication, and then they will see how well it works to shrink tumors. Researchers want to understand how this treatment works in your body and what side effects people might experience.
Many people with this type of lung cancer don't have good treatment options, especially when their cancer has this particular genetic change. This trial exists to see if this new medication could help slow or stop the cancer's growth in patients who haven't had other options work.
You would receive the medication on a schedule determined by your doctor, likely visiting the clinic regularly for check-ins, blood tests, and scans to monitor how you're responding. The study starts with a dose-finding phase where doctors carefully increase the dose to find the safest amount, then moves to a phase where more patients receive the dose that worked best. Throughout the trial, your doctors will watch closely for any side effects and measure whether the medication is helping shrink your tumor.
AI-generated summary from trial data · Sep 19, 2026 · Not medical advice
United States